← FDA Warning Letters
North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding
FDA Warning Letter · 2023-01-24 · Division of Pharmaceutical Quality Operations II
Letter
- Company
- North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding
- Posted Date
- 2023-01-24
- Letter Issue Date
- 2022-11-18
- Issuing Office
- Division of Pharmaceutical Quality Operations II
Subject
Compounding Pharmacy/Adulterated Drug Products
Source
- Authoritative
- FDA Warning Letters
- Machine
- JSON-LD · Markdown